September 26, 2016 4:22 AM ET

Pharmaceuticals

Company Overview of Wyeth LLC

Company Overview

Wyeth LLC develops, manufactures, distributes, and markets pharmaceutical products the United States, the United Kingdom, and internationally. The company’s Pharmaceuticals segment offers neuroscience therapies, vaccines, musculoskeletal therapies, nutritional products, gastroenterology drugs, anti-infectives, oncology therapies, hemophilia treatments, immunological products, and women's healthcare products. It offers its products to wholesalers, pharmacies, hospitals, governments, physicians, retailers, and other human healthcare institutions. The company's Consumer Healthcare segment develops, manufactures, distributes, and markets over-the-counter healthcare products comprising analgesics...

235 East 42nd Street

New York, NY 10017-5703

United States

Founded in 1926

47,426 Employees

Phone:

973-660-5000

Fax:

973-660-7528

Key Executives for Wyeth LLC

Chief Counsel and Senior Vice President
Age: 60
Executive Vice President of Technical Operations and Product Supply Operational Excellence
Age: 66
Principal Corporate Officer and Vice President of Internal Audit
Vice President of Taxes and Member of Finance and Retirement Committees
Age: 75
Compensation as of Fiscal Year 2016.

Wyeth LLC Key Developments

Wyeth Reaches Agreement in Principle to Resolve Medicaid Drug Rebate Claims for 2001-2006 Period for Protonix

Pfizer Inc. reported that its Wyeth subsidiary has reached an agreement in principle to resolve claims alleging that Wyeth's practices relating to the calculation of Medicaid rebates for its drug Protonix (pantoprazole sodium) between 2001 and 2006, several years before Pfizer acquired Wyeth in 2009, violated the Federal Civil False Claims Act and other laws. When finalized, the agreement in principle is expected to fully resolve cases pending in Federal District Court for the District of Massachusetts before the Honorable Douglas P. Woodlock. Under the agreement in principle, Wyeth will make a payment of $784.6 million to resolve these claims. The agreement in principle does not include an admission of liability by Wyeth. The resolution is subject to the negotiation of final settlement agreements and court approval.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Wyeth LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.